Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Establishing Correlates of Protection for Vaccine Development: Considerations for the Respiratory Syncytial Virus Vaccine Field
Prasad S. Kulkarni, Julia L. Hurwitz, Eric A. F. Simões, et al.
Viral Immunology (2018) Vol. 31, Iss. 2, pp. 195-203
Open Access | Times Cited: 53

Showing 26-50 of 53 citing articles:

Current state and challenges in respiratory syncytial virus drug discovery and development
Gang Zou, Sushan Cao, Zhao Gao, et al.
Antiviral Research (2023) Vol. 221, pp. 105791-105791
Closed Access | Times Cited: 7
Respiratory syntycial virus: Current treatment strategies and vaccine approaches
Elena Margret Thornhill, Jessica Salpor, David Verhoeven
Antiviral chemistry & chemotherapy (2020) Vol. 28, pp. 204020662094730-204020662094730
Open Access | Times Cited: 16
RSV Vaccine Based on Rhabdoviral Vector Protects after Single Immunization
Sarah Wilmschen, Sabrina Schneider, Felix Peters, et al.
Vaccines (2019) Vol. 7, Iss. 3, pp. 59-59
Open Access | Times Cited: 15
RSV Neutralizing Antibodies Following Nirsevimab and Palivizumab Dosing
Deidre Wilkins, Ulrika Wählby Hamrén, Yue Chang, et al.
PEDIATRICS (2024) Vol. 154, Iss. 5
Closed Access | Times Cited: 1
Will Attention by Vaccine Developers to the Host’s Nuclear Hormone Levels and Immunocompetence Improve Vaccine Success?
Robert E. Sealy, Bart G. Jones, Sherri L. Surman, et al.
Vaccines (2019) Vol. 7, Iss. 1, pp. 26-26
Open Access | Times Cited: 14
Vaccine-induced antibody Fc-effector functions in humans immunized with a combination Ad26.RSV.preF/RSV preF protein vaccine
Yannic C. Bartsch, Deniz Cizmeci, Dansu Yuan, et al.
Journal of Virology (2023) Vol. 97, Iss. 11
Open Access | Times Cited: 4
Longitudinal study of the immune response and memory following natural bovine respiratory syncytial virus infections in cattle of different age
Sara Hägglund, Katarina Näslund, Anna Svensson, et al.
PLoS ONE (2022) Vol. 17, Iss. 9, pp. e0274332-e0274332
Open Access | Times Cited: 7
Structure basis of neutralization by a novel site II/IV antibody against respiratory syncytial virus fusion protein
Qingqing Xie, Zhao Wang, Fengyun Ni, et al.
PLoS ONE (2019) Vol. 14, Iss. 2, pp. e0210749-e0210749
Open Access | Times Cited: 10
Correlates of Protection
Stanley A. Plotkin, Peter B. Gilbert
Elsevier eBooks (2023), pp. 45-51.e5
Closed Access | Times Cited: 3
Adapting COVID-19 research infrastructure to capture influenza and respiratory syncytial virus alongside SARS-CoV-2 in UK healthcare workers winter 2022/23 and beyond: protocol for a pragmatic sub-study
Jonathan Broad, Dominic Sparkes, Naomi Platt, et al.
NIHR Open Research (2024) Vol. 4, pp. 1-1
Open Access
Peer Review Report For: Adapting COVID-19 research infrastructure to capture influenza and respiratory syncytial virus alongside SARS-CoV-2 in UK healthcare workers winter 2022/23 and beyond: protocol for a pragmatic sub-study [version 1; peer review: 1 approved with reservations]
Fiona May
(2024)
Open Access
Clinical validation of an RSV neutralization assay and testing of cross-sectional sera pre- and post- RSV outbreaks from 2021-2023
Eli A. Piliper, Jonathan C. Reed, Alexander L. Greninger
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Adapting COVID-19 research infrastructure to capture influenza and respiratory syncytial virus alongside SARS-CoV-2 in UK healthcare workers winter 2022/23 and beyond: protocol for a pragmatic sub-study
Jonathan Broad, Dominic Sparkes, Naomi Platt, et al.
NIHR Open Research (2024) Vol. 4, pp. 1-1
Open Access
Peer Review Report For: Adapting COVID-19 research infrastructure to capture influenza and respiratory syncytial virus alongside SARS-CoV-2 in UK healthcare workers winter 2022/23 and beyond: protocol for a pragmatic sub-study [version 2; peer review: 1 approved, 1 approved with reservations]
Isabell Wagenhäuser
(2024)
Open Access
Clinical validation of an RSV neutralization assay and analysis of cross-sectional sera associated with 2021–2023 RSV outbreaks to investigate the immunity debt hypothesis
Eli A. Piliper, Jonathan C. Reed, Alexander L. Greninger
Microbiology Spectrum (2024)
Closed Access
Adapting COVID-19 research infrastructure to capture influenza and respiratory syncytial virus alongside SARS-CoV-2 in UK healthcare workers winter 2022/23 and beyond: protocol for a pragmatic sub-study
Jonathan Broad, Dominic Sparkes, Naomi Platt, et al.
NIHR Open Research (2024) Vol. 4, pp. 1-1
Open Access

Giovanna Elisa Calabrò, Caterina Rizzo, Alexander Domnich, et al.
PubMed (2024) Vol. 65, Iss. 2 Suppl 1, pp. E1-E159
Closed Access
Self-amplifying mRNA vaccines protect elderly BALB/c mice against a lethal respiratory syncytial virus infection
Lulu Zuo, Qixing Liu, Ke Zhang, et al.
Molecular Therapy (2024)
Closed Access
Peer Review Report For: Adapting COVID-19 research infrastructure to capture influenza and respiratory syncytial virus alongside SARS-CoV-2 in UK healthcare workers winter 2022/23 and beyond: protocol for a pragmatic sub-study [version 3; peer review: 1 approved, 2 approved with reservations]
Ram Kumar Garg
(2024)
Closed Access
Humoral and Mucosal Antibody Response to RSV Structural Proteins in RSV-Infected Adult Hematopoietic Cell Transplant (HCT) Recipients
Xunyan Ye, Obinna P. Iwuchukwu, Vasanthi Avadhanula, et al.
Viruses (2021) Vol. 13, Iss. 6, pp. 991-991
Open Access | Times Cited: 4
Adapting COVID-19 research infrastructure to capture Influenza and Respiratory Syncytial Virus alongside SARS-CoV-2 in UK healthcare workers Winter 2022/23 and beyond: protocol for a pragmatic sub-study
Jonathan Broad, Dominic Sparkes, Naomi Platt, et al.
medRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 1
Vaccine Design Informed by Virus-Induced Immunity
Rhiannon R. Penkert, Jane S. Hankins, Neal S. Young, et al.
Viral Immunology (2020) Vol. 33, Iss. 4, pp. 342-350
Open Access | Times Cited: 2
Approaching the End of the Era of Uncontrolled Respiratory Syncytial Virus Disease
H. Cody Meissner
The Journal of Infectious Diseases (2020) Vol. 223, Iss. 5, pp. 737-739
Open Access | Times Cited: 2
Combination Ad26.RSV.preF/RSV preF protein vaccine induces superior humoral, cellular, and protective immunity compared with individual vaccine components in preclinical models
Eiríkur Saeland, Leslie van der Fits, Renske Bolder, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 1
Virus reduction neutralization test and LI-COR microneutralization assay bridging and WHO international standard calibration studies for respiratory syncytial virus
Dengyun Sun, Ying Homan, Joseph M. Antonello, et al.
Bioanalysis (2022) Vol. 14, Iss. 15, pp. 1067-1079
Closed Access | Times Cited: 1

Scroll to top